NDC 71335-0595-04 - bisoprolol fumarate and hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-0595
- Requested NDC
- 71335-0595-04
- Package NDCs from labels
- 71335-0595-1, 71335-0595-2, 71335-0595-3, 71335-0595-4, 71335-0595-04
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-10-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| bisoprolol fumarate and hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-10-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-0595-1 | bisoprolol fumarate and hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 105 | |
| 71335-0595-2 | bisoprolol fumarate and hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 105 | |
| 71335-0595-3 | bisoprolol fumarate and hydrochlorothiazide | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | 105 | |
| 71335-0595-4 | bisoprolol fumarate and hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 105 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-0595 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 105 | Current NDC, Legacy NDC, 4 package rows | 20240524_447c11b6-72fe-418e-a2db-5d90b5347796.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-0595-1 | EA - Each | 71335-0595 | 95c7514a-5554-4930-9875-b8e59c862030 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50 | TITANIUM DIOXIDE, ZINC OXIDE | COOLA, LLC | cb95c712-1680-4040-e053-2995a90af004 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | c182b6a9-1a31-45ee-9cea-a557c99f5db7 | 2026-11-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | 303d5d5a-4c7a-1e23-e063-6294a90a0e58 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | EAI-JR 286, Inc. | b9ea12e8-6ed9-d805-e053-2a95a90aa107 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Pearl White Face Stick SPF 50 | PADIMATE O, TITANIUM DIOXIDE | Eai-jr 286, Inc | b69a75e0-8724-35ae-e053-2a95a90a5f34 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra S Dorian Kona Gold Signature Face Stick SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | b6c316c3-661b-6428-e053-2a95a90a1a6b | 2026-11-04 | Warnings | 15FIX9V2JP |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2026-11-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd | 2026-11-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98a58b54-bcf2-4726-800a-facf48d9155f | 2026-11-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 1dc47186-3ecf-456f-b6d6-ba0f75c2504b | 2026-11-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| BISOPROLOL FUMARATE | BISOPROLOL FUMARATE | PD-Rx Pharmaceuticals, Inc. | c8fa858c-7e42-4134-9fc6-604a11a66fe2 | 2026-11-02 | Warnings, Adverse reactions | UR59KN573L |
| BISOPROLOL FUMARATE | BISOPROLOL FUMARATE | PD-Rx Pharmaceuticals, Inc. | 6566dcbe-3e25-4828-9c10-3d041000bc77 | 2026-11-02 | Warnings, Adverse reactions | UR59KN573L |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Coupler LLC | 5f4e3bc8-2810-f1ae-e063-6394a90a9725 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.